RNAZ TRANSCODE THERAPEUTICS INC

Ownership history in DRW Securities, LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which DRW Securities, LLC reported a position in TRANSCODE THERAPEUTICS INC (RNAZ). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 11,702 0.00% $126K $10.75
% of Fund (quarterly)    RNAZ price (monthly, adj. close)
← Back to DRW Securities, LLC Holdings